Cargando…
Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS
Skeletal muscle fatigue and post-exertional malaise are key symptoms of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (ME/CFS). We have previously shown that AMP-activated protein kinase (AMPK) activation and glucose uptake are impaired in primary human skeletal muscle cell cultures derive...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938427/ https://www.ncbi.nlm.nih.gov/pubmed/29654166 http://dx.doi.org/10.1042/BSR20180242 |
_version_ | 1783320781001850880 |
---|---|
author | Brown, Audrey E. Dibnah, Beth Fisher, Emily Newton, Julia L. Walker, Mark |
author_facet | Brown, Audrey E. Dibnah, Beth Fisher, Emily Newton, Julia L. Walker, Mark |
author_sort | Brown, Audrey E. |
collection | PubMed |
description | Skeletal muscle fatigue and post-exertional malaise are key symptoms of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (ME/CFS). We have previously shown that AMP-activated protein kinase (AMPK) activation and glucose uptake are impaired in primary human skeletal muscle cell cultures derived from patients with ME/CFS in response to electrical pulse stimulation (EPS), a method which induces contraction of muscle cells in vitro. The aim of the present study was to assess if AMPK could be activated pharmacologically in ME/CFS. Primary skeletal muscle cell cultures from patients with ME/CFS and healthy controls were treated with either metformin or compound 991. AMPK activation was assessed by Western blot and glucose uptake measured. Both metformin and 991 treatment significantly increased AMPK activation and glucose uptake in muscle cell cultures from both controls and ME/CFS. Cellular ATP content was unaffected by treatment although ATP content was significantly decreased in ME/CFS compared with controls. Pharmacological activation of AMPK can improve glucose uptake in muscle cell cultures from patients with ME/CFS. This suggests that the failure of EPS to activate AMPK in these muscle cultures is due to a defect proximal to AMPK. Further work is required to delineate the defect and determine whether pharmacological activation of AMPK improves muscle function in patients with ME/CFS. |
format | Online Article Text |
id | pubmed-5938427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59384272018-05-15 Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS Brown, Audrey E. Dibnah, Beth Fisher, Emily Newton, Julia L. Walker, Mark Biosci Rep Research Articles Skeletal muscle fatigue and post-exertional malaise are key symptoms of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (ME/CFS). We have previously shown that AMP-activated protein kinase (AMPK) activation and glucose uptake are impaired in primary human skeletal muscle cell cultures derived from patients with ME/CFS in response to electrical pulse stimulation (EPS), a method which induces contraction of muscle cells in vitro. The aim of the present study was to assess if AMPK could be activated pharmacologically in ME/CFS. Primary skeletal muscle cell cultures from patients with ME/CFS and healthy controls were treated with either metformin or compound 991. AMPK activation was assessed by Western blot and glucose uptake measured. Both metformin and 991 treatment significantly increased AMPK activation and glucose uptake in muscle cell cultures from both controls and ME/CFS. Cellular ATP content was unaffected by treatment although ATP content was significantly decreased in ME/CFS compared with controls. Pharmacological activation of AMPK can improve glucose uptake in muscle cell cultures from patients with ME/CFS. This suggests that the failure of EPS to activate AMPK in these muscle cultures is due to a defect proximal to AMPK. Further work is required to delineate the defect and determine whether pharmacological activation of AMPK improves muscle function in patients with ME/CFS. Portland Press Ltd. 2018-05-08 /pmc/articles/PMC5938427/ /pubmed/29654166 http://dx.doi.org/10.1042/BSR20180242 Text en © 2018 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Articles Brown, Audrey E. Dibnah, Beth Fisher, Emily Newton, Julia L. Walker, Mark Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS |
title | Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS |
title_full | Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS |
title_fullStr | Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS |
title_full_unstemmed | Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS |
title_short | Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS |
title_sort | pharmacological activation of ampk and glucose uptake in cultured human skeletal muscle cells from patients with me/cfs |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938427/ https://www.ncbi.nlm.nih.gov/pubmed/29654166 http://dx.doi.org/10.1042/BSR20180242 |
work_keys_str_mv | AT brownaudreye pharmacologicalactivationofampkandglucoseuptakeinculturedhumanskeletalmusclecellsfrompatientswithmecfs AT dibnahbeth pharmacologicalactivationofampkandglucoseuptakeinculturedhumanskeletalmusclecellsfrompatientswithmecfs AT fisheremily pharmacologicalactivationofampkandglucoseuptakeinculturedhumanskeletalmusclecellsfrompatientswithmecfs AT newtonjulial pharmacologicalactivationofampkandglucoseuptakeinculturedhumanskeletalmusclecellsfrompatientswithmecfs AT walkermark pharmacologicalactivationofampkandglucoseuptakeinculturedhumanskeletalmusclecellsfrompatientswithmecfs |